C4 Therapeutics Overview
C4 Therapeutics Discounted Cash Flow
DCF Analysis for CCCC.
Get informed when a big investor buys or sells
+ FollowFair Value
$-3.18
Current Fair Value
$-3.18
↓ 183.2% Downside
Overvalued by 183.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison